# Study of VVN001 Ophthalmic Solution in Dry Eye Disease

> **NCT04556838** · PHASE2 · COMPLETED · sponsor: **VivaVision Biotech, Inc** · enrollment: 169 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** VVN001 Ophthalmic Solution 1%
- **DRUG:** VVN001 Ophthalmic Solution 5%
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT04556838
- **Lead sponsor:** VivaVision Biotech, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-03
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2023-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04556838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04556838, "Study of VVN001 Ophthalmic Solution in Dry Eye Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04556838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*